Economic burden of patients with leading cancers in China: a cost-of-illness study

Economic burden of patients with leading cancers in China: a cost-of-illness study

Abstract Background China accounts for 24% of newly diagnosed cancer cases and 30% of cancer-related deaths worldwide. Comprehensive analyses of the economic burden on patients across different cancer treatment phases, based on empirical data, are lacking. This study aims to estimate the financial b...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy: Ziting Wu, Yiwen Yu, Feng Xie, Qiushi Chen, Zhong Cao, Simiao Chen, Gordon G. Liu
Format: Artykuł
Język:English
Wydane: BMC 2024-09-01
Seria:BMC Health Services Research
Hasła przedmiotowe:
Cost-of-illness
Cancer costs
China
Treatment phases
Dostęp online:https://doi.org/10.1186/s12913-024-11514-x

Internet

https://doi.org/10.1186/s12913-024-11514-x

Podobne zapisy